HIGHLIGHTS
- who: Alireza Mousavi and colleagues from the Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran have published the research work: 2-(Nitroaryl)-5-Substituted-1,3,4-Thiadiazole Derivatives with Antiprotozoal Activities: In Vitro and In Vivo Study, in the Journal: Molecules 2022, 5559 of 26/08/2022
- what: The authors demonstrated that these compounds present noteworthy in_vitro trypanocidal activity.
- how: The pharmacokinetic profile of the compounds was predicted by the SwissADME webbased tool and the results are shown in Table 4 .
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.